NexImmune Management
Management criteria checks 2/4
NexImmune's CEO is Kristi Jones, appointed in Feb 2022, has a tenure of 1.92 years. total yearly compensation is $2.15M, comprised of 23.8% salary and 76.2% bonuses, including company stock and options. directly owns 0.28% of the company’s shares, worth €27.31K. The average tenure of the management team and the board of directors is 2.5 years and 3.6 years respectively.
Key information
Kristi Jones
Chief executive officer
US$2.2m
Total compensation
| CEO salary percentage | 23.8% |
| CEO tenure | 1.9yrs |
| CEO ownership | 0.3% |
| Management average tenure | 2.5yrs |
| Board average tenure | 3.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$44m |
| Jun 30 2023 | n/a | n/a | -US$49m |
| Mar 31 2023 | n/a | n/a | -US$57m |
| Dec 31 2022 | US$2m | US$512k | -US$63m |
| Sep 30 2022 | n/a | n/a | -US$61m |
| Jun 30 2022 | n/a | n/a | -US$61m |
| Mar 31 2022 | n/a | n/a | -US$57m |
| Dec 31 2021 | US$2m | US$363k | -US$51m |
| Sep 30 2021 | n/a | n/a | -US$45m |
| Jun 30 2021 | n/a | n/a | -US$39m |
| Mar 31 2021 | n/a | n/a | -US$35m |
| Dec 31 2020 | US$397k | US$308k | -US$33m |
| Sep 30 2020 | n/a | n/a | -US$30m |
| Dec 31 2019 | US$564k | US$298k | -US$23m |
Compensation vs Market: Kristi's total compensation ($USD2.15M) is above average for companies of similar size in the German market ($USD402.55K).
Compensation vs Earnings: Kristi's compensation has increased whilst the company is unprofitable.
CEO
Kristi Jones (60 yo)
1.9yrs
Tenure
US$2,152,286
Compensation
Ms. Kristi Jones, R.P.H. serves as Chief Executive Officer, President and Director at NexImmune, Inc. since February 2022 and served as its Chief Operating Officer from March 2018 until February 2022. She...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.9yrs | US$2.15m | 0.28% $ 27.3k | |
| Chief Scientific Officer | 1.8yrs | US$853.73k | 0.030% $ 3.0k | |
| Consultant | less than a year | US$831.20k | 0% $ 0 | |
| Consultant | 3yrs | US$852.79k | no data | |
| VP, Corporate Controller and Principal Financial & Accounting Officer | 2.6yrs | no data | 0% $ 0 | |
| Head of Human Resources | no data | no data | no data | |
| Senior Vice President of Molecular Engineering & Protein Design | 6.7yrs | no data | no data | |
| Chief Medical Officer | 3yrs | US$2.91m | 0% $ 0 | |
| Senior Vice President of Corporate Affairs | 2.8yrs | no data | no data | |
| Senior Vice President of Translational Science | 2.5yrs | no data | no data | |
| Head of Business Development | 2.5yrs | no data | no data |
2.5yrs
Average Tenure
60yo
Average Age
Experienced Management: 7370's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.9yrs | US$2.15m | 0.28% $ 27.3k | |
| Independent Chairman of the Board | 4.2yrs | US$102.00k | 15.51% $ 1.5m | |
| Chair of Autoimmune & Infectious Disease Scientific Advisory Board | 2yrs | no data | no data | |
| Independent Director | 6.9yrs | US$62.50k | 0% $ 0 | |
| Independent Director | 7yrs | US$64.00k | 0.048% $ 4.7k | |
| Chief Scientific Advisor | 2.7yrs | no data | no data | |
| Independent Director | 7yrs | US$57.50k | 0.30% $ 29.2k | |
| Independent Director | 3yrs | US$44.00k | 4.18% $ 413.2k | |
| Co-Chairman of Scientific Advisory Board | 12yrs | no data | no data | |
| Independent Director | 7yrs | US$62.50k | 0.11% $ 10.4k | |
| Member of Scientific Advisory Board | 2.7yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.7yrs | no data | no data |
3.6yrs
Average Tenure
60yo
Average Age
Experienced Board: 7370's board of directors are considered experienced (3.6 years average tenure).